JNJ - Johnson & Johnson
| Previous Close | 138.84 |
| Open | 139.50 |
| Bid | 138.72 x 800 |
| Ask | 139.26 x 800 |
| Day's Range | 138.56 - 139.50 |
| 52 Week Range | 118.62 - 148.99 |
| Volume | 5,473,499 |
| Avg. Volume | 6,190,411 |
| Market Cap | 368.655B |
| Beta (3Y Monthly) | 0.68 |
| PE Ratio (TTM) | 25.73 |
| EPS (TTM) | 5.40 |
| Earnings Date | Jul 16, 2019 |
| Forward Dividend & Yield | 3.80 (2.69%) |
| Ex-Dividend Date | 2019-05-24 |
| 1y Target Est | 148.12 |
- Reuters•3 hours ago
UPDATE 1-Teva Pharm to pay Oklahoma $85 mln to settle opioid claims
BOSTON/JERUSALEM, May 26 (Reuters) - Teva Pharmaceutical Industries said on Sunday it had agreed an $85 million settlement with the state of Oklahoma days before the company was set to face trial over allegations that it and other drugmakers helped to fuel the U.S. opioid epidemic. Teva, the world's largest generic drugmaker, said the settlement "does not establish any wrongdoing on the part of the company" and denied contributing to opioid abuse in Oklahoma. Claims against Teva focused on the branded opioid products Actiq and Fentora as well as generic painkillers it produced.
- Reuters•2 days ago
UPDATE 1-Doctor, medical funder charged in New York in transvaginal mesh fraud
A doctor and a surgical funding consultant were arrested on Friday on charges that they defrauded women into having unnecessary surgeries to remove transvaginal mesh implants in order to profit from settlements paid to the women by mesh manufacturers, U.S. prosecutors in New York said. Urogynecologist Christopher Walker, 49, of Florida, and Wesley Barber, 49, of Michigan, were both charged with wire fraud and conspiracy in an indictment unsealed in federal court in Brooklyn. Barber, who is the owner of Surgical Assistance Inc and Medical Funding Consultants LLC, was arrested in Texas and Walker in Florida, authorities said.
- Bloomberg•2 days ago
Drug Makers' Opioid Liability Tied to Untested Legal Theory
Oklahoma is the first to go to trial with a case relying on nuisance laws normally invoked for minor property disputes involving things such as loud noises or bright lights. “It’s the first time this theory has actually gotten to trial in pharmaceutical litigation, so everybody will be watching to see if it works,” said Richard C. Ausness, a University of Kentucky law professor who monitors opioid litigation. Oklahoma Attorney General Mike Hunter claims J&J and Teva are liable for at least $10 billion in damages from the state’s two-decade surge in opioid addiction.
- Zacks•2 days ago
Pharma Stock Roundup: MRK's Cancer Biotech Buyout, ABBV, LLY's Pipeline Updates
Key highlights of the week include Merck's (MRK) offer to buy private cancer biotech and AbbVie (ABBV) and Lilly's (LLY) updates from clinical studies.
- Zacks•2 days ago
Dow 30 Stock Roundup: Home Depot Earnings Impress, Merck to Buy Peloton Therapeutics
The index suffered a difficult week as investors braced for a protracted U.S.-China trade war.
- Reuters•2 days ago
PREVIEW-Oklahoma takes on drugmakers J&J, Teva in landmark opioid trial
Gail Box vividly remembers the day in May 2011 when she first learned her 22-year-old son Austin, a University of Oklahoma linebacker, was abusing opioid painkillers: It was the day he died of an overdose. In a few months he had gone from taking pills prescribed for a back injury to illicitly obtaining more of the addictive drugs from acquaintances. Oklahoma Attorney General Mike Hunter's $17 billion lawsuit is the first to go to trial of more than 2,000 actions by state and local governments accusing opioid manufacturers of contributing to an epidemic linked to a record 47,600 overdose deaths in 2017, according to the U.S. Centers for Disease Control and Prevention.
- Motley Fool•3 days ago
Better Buy: Johnson & Johnson vs. GlaxoSmithKline
Which of these top dividend-paying pharma stocks is the better buy right now?
- Zacks•3 days ago
J&J's Invokana sNDA Gets Priority Review Status From FDA
FDA grants priority review to J&J's (JNJ) Invokana sNDA for the treatment of chronic kidney disease in patients with type II diabetes
- Reuters•3 days ago
UPDATE 2-U.N. creates new Ebola chief role to tackle security, political issues in Congo
The United Nations named an Emergency Ebola Response Coordinator on Thursday, a new position to boost efforts to contain a 10-month epidemic in the Democratic Republic of Congo that has killed 1,241 people and is spreading. The drive to rein in the deadly virus has been hampered by attacks on treatment centers by armed groups operating in Congo’s lawless east and by distrust among residents, many of whom view the disease as a conspiracy.
- Zacks•4 days ago
Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know
Johnson & Johnson (JNJ) closed the most recent trading day at $138.76, moving +0.46% from the previous trading session.
- Reuters•4 days ago
Congo wants more use of Merck vaccine rather than J&J newcomer - minister
Democratic Republic of Congo called on Wednesday for Merck's experimental Ebola vaccine to be fully licensed to facilitate its use in the Ebola-hit country, while saying Johnson & Johnson's rival drug would complicate matters. Both vaccines are experimental drugs that can be used under strictly controlled research protocols but Merck's has been used throughout the outbreak and has proven highly effective, the World Health Organization (WHO) says. Congolese Health Minister Oly Ilunga Kalenga told reporters in Geneva that the government would roll out a "geographic ring" vaccination strategy in the coming days.
- Zacks•5 days ago
The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix
The Zacks Analyst Blog Highlights: Johnson & Johnson, Apple, Goldman Sachs, IBM and Netflix
- Zacks•6 days ago
Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs
Top Analyst Reports for Johnson & Johnson, Apple & Goldman Sachs
- Zacks•6 days ago
This is Why Johnson & Johnson (JNJ) is a Great Dividend Stock
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.
- Zacks•6 days ago
AbbVie's Brain Cancer Candidate Fails in Phase III Study
AbbVie's (ABBV) phase III study on Depatux-M, an investigational candidate for newly diagnosed glioblastoma, fails to show survival benefit in patients receiving Depatux-M.
- Reuters•7 days ago
INSIGHT-Modi’s jobs deficit: J&J’s largest India plant idle 3 years after completion
PENJERLA/NEW DELHI, India May 19 (Reuters) - It was supposed to be Johnson & Johnson's biggest manufacturing plant in India. It was to eventually employ at least 1,500 people and help bring development to a rural area near Hyderabad in southern India. Two sources familiar with J&J's operations in India and one state government official told Reuters production at the plant, at Penjerla in Telangana state, never began because of a slowing in the growth in demand for the products.
- Motley Fool•8 days ago
6 Things Johnson & Johnson Wants You to Know About Its Pharmaceuticals
Here's what management wants investors to know about the future of the company's pharmaceutical segment.
Reuters•9 days agoExclusive: FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case - sources
The U.S. FBI is investigating corporate giants Johnson & Johnson, Siemens AG, General Electric Co and Philips for allegedly paying kickbacks as part of a scheme involving medical equipment sales in Brazil, two Brazilian investigators have told Reuters. Brazilian prosecutors suspect the companies channeled illegal payoffs to government officials to secure contracts with public health programs across the South American country over the past two decades. Brazilian authorities say more than 20 companies may have been part of a "cartel" that paid bribes and charged the government inflated prices for medical gear such as magnetic resonance imaging machines and prosthetics.
- Reuters•9 days ago
EXCLUSIVE-FBI targets Johnson & Johnson, Siemens, GE, Philips in Brazil graft case -Sources
The U.S. FBI is investigating corporate giants Johnson & Johnson, Siemens AG, General Electric Co and Philips for allegedly paying kickbacks as part of a scheme involving medical equipment sales in Brazil, two Brazilian investigators have told Reuters. Brazilian prosecutors suspect the companies channeled illegal payoffs to government officials to secure contracts with public health programs across the South American country over the past two decades. Brazilian authorities say more than 20 companies may have been part of a "cartel" that paid bribes and charged the government inflated prices for medical gear such as magnetic resonance imaging machines and prosthetics.
- CNBC•9 days ago
Your first trade for Friday, May 17
The " Fast Money " traders shared their first moves for the market open.Pete Najarian was a buyer of Lennar LEN .Tim Seymour was a buyer of Johnson & Johnson JNJ .Dan Nathan was a seller of Boeing BA .
- Zacks•9 days ago
Pharma Stock Roundup: FDA Okays Line Extensions of LLY, PFE, ABBV Cancer Drugs
FDA grants approval for line extensions of Lilly (LLY), Pfizer (PFE) and Roche (RHHBY)/AbbVie's (ABBV) cancer drugs
- Motley Fool•10 days ago
Did Geron's Big Announcement Just Go Unnoticed?
Geron hints at a way forward for imetelstat in myelofibrosis, but the market isn't buying it.
